Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2025 Mar;52(4):1246-1248.
doi: 10.1007/s00259-024-07039-4.

Cardiovascular disease and radiopharmaceutical therapies- an underestimated risk?

Michael Lassmann  1 , Uta Eberlein  2 , Frederik A Verburg  3
Affiliations
Editorial

Cardiovascular disease and radiopharmaceutical therapies- an underestimated risk?

Michael Lassmann et al. Eur J Nucl Med Mol Imaging. 2025 Mar.
No abstract available

Keywords: Absorbed dose; Cardiovascular disease; Radiopharmaceutical therapy.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethical approval: Not applicable. Informed consent: Not applicable. Conflict of interest: ML has received institutional grants from Novartis and Pentixapharm. UE declares no conflict of interest. FAV is a consultant to GE Healthcare and Immedica and has received speaker honoraria from Bayer and GE Healthcare (all payments made by employer).

References

    1. WHO. The top 10 causes of death. 2024. https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases.... Accessed 12/18/2024.
    1. Little MP, Azizova TV, Richardson DB, Tapio S, Bernier M-O, Kreuzer M, et al. Ionising radiation and cardiovascular disease: systematic review and meta-analysis. BMJ. 2023;e072924. 10.1136/bmj-2022-072924. - PMC - PubMed
    1. Jahng JWS, Little MP, No HJ, Loo BW, Wu JC. Consequences of ionizing radiation exposure to the cardiovascular system. Nat Reviews Cardiol. 2024. 10.1038/s41569-024-01056-4. - DOI - PMC - PubMed
    1. Kolbert KS, Pentlow KS, Pearson JR, Sheikh A, Finn RD, Humm JL, et al. Prediction of absorbed dose to normal organs in thyroid cancer patients treated with 131I by use of 124I PET and 3-dimensional internal dosimetry software. J Nucl Med. 2007;48:143–9. - PubMed
    1. Verburg FA, Lassmann M, Mader U, Luster M, Reiners C, Hänscheid H. The absorbed dose to the blood is a better predictor of ablation success than the administered 131I activity in thyroid cancer patients. Eur J Nucl Med Mol Imaging. 2011;38:673–80. 10.1007/s00259-010-1689-5. - DOI - PubMed

Publication types

LinkOut - more resources